Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.

Zhang, Zong-Lin

Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. [electronic resource] - Breast cancer (Tokyo, Japan) Mar 2018 - 233-242 p. digital

Publication Type: Journal Article

1880-4233

10.1007/s12282-017-0821-9 doi


ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics
Antibiotics, Antineoplastic--pharmacology
Apoptosis--drug effects
Biomarkers, Tumor--genetics
Breast Neoplasms--drug therapy
Cyclooctanes--pharmacology
Doxorubicin--pharmacology
Drug Resistance, Multiple--drug effects
Drug Resistance, Neoplasm--drug effects
Female
Gene Expression Regulation, Neoplastic--drug effects
Humans
Lignans--pharmacology
Phosphorylation
Polycyclic Compounds--pharmacology
STAT3 Transcription Factor--genetics
Signal Transduction--drug effects
Transcription Factor RelA--genetics
Tumor Cells, Cultured